Inhibitory effects of recombinant human parvovirus H-1 vector expressing p21 (rhH1 Δ/p21) on the growth of human gastric cancer cell line HGC27
- Author:
Zhi-Hua RAN
1
Author Information
1. Department of Gastroenterology
- Publication Type:Journal Article
- Keywords:
Cell cycle;
DNA, recombinant;
Gene expressions;
Oncogene protein p21;
Parvoviride infections;
Stomach neoplasms
- From:
Tumor
2007;27(4):251-255
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the effects of recombinant parvovirus H-1 vector expressing p21(rhH1 Δ p21) on human gastric cancer cell line HGC27, and to further reveal the biological function of p21wif1 to provide the basis for cancer gene therapy. Methods: The recombinant parvovirus H-1 vector expressing p21 (rhH1 Δ/p21) was constructed by reverse transcriptase-polymerase chain reaction (RT-PCR), and was transfected into HGC27 cell line. The morphological changes of HGC27 cell were observed. The transgene protein expressions in the gastric cancer cells were detected by Western blot. The inhibitory effects of rhH1 Δ/p21 on the growth of HGC27 cells were measured by MTT assay. The cell cycle distribution was determined by flowcytometry. Results: The rhH1 Δ/p21 was successfully constructed, with a titer of 3.5 × 107 PFU/mL. The transgene protein p21 was over-expressed in the HGC27 cells. The cell cycle distribution was changed. The proportion of cells in G1 phase significantly increased. The cell growth was significantly inhibited. Conclusion: rhH1 Δ/p21 induces G1 arrest and inhibits the proliferation of gastric cancer HGC27 cells. It indicates that rhH1 Δ/p21 gene therapy can effectively inhibit the growth of gastric cancer cells in vitro.
